Mylotte J M, Naughton B, Saludades C, Maszarovics Z
Dept. of Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Erie County Medical Center, 14215, USA.
J Am Geriatr Soc. 1998 Dec;46(12):1538-44. doi: 10.1111/j.1532-5415.1998.tb01539.x.
To evaluate the predictability of a pneumonia prognosis index in nursing home residents with pneumonia and to use the index to account for acute severity of pneumonia before comparing the short-term outcome of residents with pneumonia treated with intravenous antibiotic therapy in two different settings: an inpatient geriatrics unit and a nursing home
A retrospective chart review of 158 episodes of nursing home-acquired pneumonia treated initially with intravenous antibiotics; 100 episodes were treated in an inpatient acute geriatrics service (AGS), and 58 were treated completely in a nursing home (Nursing Home group)
The AGS is a 20-bed unit within a 400-bed, public, university-affiliated hospital. The Nursing Home group consisted of residents of two nonproprietary nursing homes.
Nursing home residents with radiographically proven pneumonia who had at least one of the following signs/symptoms: cough, fever, purulent sputum, respiratory rate > or = 25 per minute, localized auscultatory findings, or pleuritic pain.
The pneumonia prognosis index was calculated for each resident at the time of diagnosis of pneumonia; the index has been validated as a predictor of hospital outcome in patients with community-acquired pneumonia and is also considered a measure of acute severity of pneumonia. Status (alive or dead) of each resident at 30 days after diagnosis was the major dependent variable
Mean (+/-SD) duration of antibiotic therapy for the Nursing Home group (10.7+/-4.5 days) was not significantly different from that of the AGS group (9.6+/-3.4 days; P = .26). The pneumonia prognosis index stratified the 158 episodes of pneumonia into low- and high-risk groups for 30-day mortality; the mortality rates in each risk strata were not significantly different from those reported in the original derivation and validation studies of the index. In addition, the distribution of episodes among the risk strata of the index was not significantly different for the two study groups, which was an indication that the two groups were similar in terms of acute severity of pneumonia. Thirty-day mortality was not significantly different between the two groups: AGS, 21% and Nursing Home, 24.1% (P = .66).
The pneumonia prognosis index seems to have the same capability for predicting the outcome in nursing home residents with pneumonia as in residents with community-acquired pneumonia. The index is also a measure of acute pneumonia severity. Nursing home residents with pneumonia, even those who are most acutely ill, can be treated successfully with intravenous therapy in the nursing home; their 30-day mortality was no different than that of those with the same acute severity of illness who were admitted to a hospital for treatment.
评估肺炎预后指数对养老院肺炎患者预后的预测能力,并在比较两种不同环境下接受静脉抗生素治疗的肺炎患者短期结局之前,使用该指数来衡量肺炎的急性严重程度。这两种环境分别是住院老年病科和养老院。
对158例最初接受静脉抗生素治疗的养老院获得性肺炎病例进行回顾性病历审查;其中100例在住院急性老年病服务(AGS)中接受治疗,58例在养老院完全接受治疗(养老院组)。
AGS是一家拥有400张床位的公立大学附属医院内的一个设有20张床位的科室。养老院组由两家非盈利性养老院的居民组成。
经影像学证实患有肺炎且至少有以下一种体征/症状的养老院居民:咳嗽、发热、脓性痰、呼吸频率≥25次/分钟、局限性听诊发现或胸膜炎性疼痛。
在肺炎诊断时为每位居民计算肺炎预后指数;该指数已被验证可作为社区获得性肺炎患者医院结局的预测指标,也被视为肺炎急性严重程度的一种衡量指标。诊断后30天每位居民的状态(存活或死亡)是主要的因变量。
养老院组抗生素治疗的平均(±标准差)持续时间为(10.7±4.5天),与AGS组(9.6±3.4天;P = 0.26)无显著差异。肺炎预后指数将158例肺炎病例分为30天死亡率的低风险和高风险组;每个风险分层中的死亡率与该指数最初的推导和验证研究报告的死亡率无显著差异。此外,该指数风险分层中病例的分布在两个研究组之间无显著差异,这表明两组在肺炎急性严重程度方面相似。两组的30天死亡率无显著差异:AGS组为21%,养老院组为24.1%(P = 0.66)。
肺炎预后指数在预测养老院肺炎患者结局方面似乎与预测社区获得性肺炎患者结局具有相同的能力。该指数也是急性肺炎严重程度的一种衡量指标。患有肺炎的养老院居民,即使是那些病情最严重的患者,在养老院接受静脉治疗也能成功治愈;他们的30天死亡率与因相同急性严重程度疾病入院治疗的患者无异。